Scarica l'app Stockscreener
1.33
5.00%
-0.07
Dopo l'orario di chiusura:
1.33
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CTXR Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.40
Aprire:
$1.52
Volume 24 ore:
2.35M
Relative Volume:
0.93
Capitalizzazione di mercato:
$22.63M
Reddito:
-
Utile/perdita netta:
$-39.14M
Rapporto P/E:
-0.2228
EPS:
-5.97
Flusso di cassa netto:
$-28.20M
1 W Prestazione:
-1.48%
1M Prestazione:
-9.52%
6M Prestazione:
-18.90%
1 anno Prestazione:
-90.61%
Intervallo 1D:
$1.31
$1.57
Intervallo di 1 settimana:
$1.23
$1.57
Portata 52W:
$0.65
$15.25
Citius Pharmaceuticals Inc Stock (CTXR) Company Profile
Nome
Citius Pharmaceuticals Inc
Settore
Industria
Telefono
(908) 967-6676
Indirizzo
11 COMMERCE DRIVE, CRANFORD, NJ
Confronta CTXR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTXR
Citius Pharmaceuticals Inc
|
1.33 | 23.82M | 0 | -39.14M | -28.20M | -5.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Citius Pharmaceuticals Inc Stock (CTXR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-30 | Aggiornamento | D. Boral Capital | Hold → Buy |
| 2021-11-30 | Iniziato | Maxim Group | Buy |
Citius Pharmaceuticals Inc Borsa (CTXR) Ultime notizie
What data driven models say about Citius Pharmaceuticals Inc.’s futureWeekly Stock Report & Technical Analysis for Trade Confirmation - Newser
What is Citius Pharmaceuticals Inc. s debt to equity ratioJuly 2025 Catalysts & Accurate Intraday Trade Tips - خودرو بانک
Citius Pharmaceuticals Soars 10.71% on Strategic Initiatives - AInvest
Citius Pharmaceuticals (CTXR) Soars 10.71% on Market Momentum - AInvest
Will Citius Pharmaceuticals Inc. see short term momentumJuly 2025 Momentum & Low Risk High Reward Trade Ideas - Newser
Will Citius Pharmaceuticals Inc. outperform the market2025 Price Momentum & Weekly Hot Stock Watchlists - Newser
Analyzing net buyer seller activity in Citius Pharmaceuticals Inc.Portfolio Profit Report & Safe Capital Growth Tips - Newser
Does Citius Pharmaceuticals Inc. qualify in momentum factor screeningJuly 2025 Setups & Safe Capital Allocation Plans - Newser
Citius Pharmaceuticals Inc. stock trendline breakdownGold Moves & Free Safe Entry Trade Signal Reports - Newser
Using economic indicators to assess Citius Pharmaceuticals Inc. potential - Newser
Is Citius Pharmaceuticals Inc. trending in predictive chart modelsQuarterly Portfolio Report & Free Community Supported Trade Ideas - Newser
Chart based analysis of Citius Pharmaceuticals Inc. trendsPortfolio Update Summary & AI Based Buy and Sell Signals - Newser
Citius Pharmaceuticals Inc. stock trend forecastQuarterly Profit Report & AI Optimized Trade Strategies - Newser
Using R and stats models for Citius Pharmaceuticals Inc. forecastingSwing Trade & Stock Market Timing Techniques - Newser
RSI Crosses Above 30 for Citius Pharmaceuticals Inc. — Reversal in SightJuly 2025 EndofMonth & Risk Adjusted Buy/Sell Alerts - beatles.ru
What is Citius Pharmaceuticals Inc.’s valuation compared to sector2025 Big Picture & High Accuracy Swing Entry Alerts - sundaytimes.kr
Why Citius Pharmaceuticals Inc. is moving todayJuly 2025 Decliners & Consistent Growth Equity Picks - Newser
How to track smart money flows in Citius Pharmaceuticals Inc.2025 Historical Comparison & Real-Time Stock Movement Alerts - Newser
Multi factor analysis applied to Citius Pharmaceuticals Inc.2025 Support & Resistance & Reliable Breakout Forecasts - Newser
Is Citius Pharmaceuticals Inc. reversing from oversold territoryMarket Risk Summary & Free Low Drawdown Momentum Trade Ideas - Newser
Citius Pharmaceuticals Inc Azioni (CTXR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):